logo
Select company
Select metric
$ -16.25MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
22
Sector
53
Industry
70
History
54
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information

Ticker

CSCIF

Company Name

COSCIENS BIOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

COSCIENS BIOPHARMA INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CSCIF - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 1.48M$ -17.73M$ -16.25M
3/31/2025$ 1.57M$ -16.93M$ -15.36M
12/31/2024$ 1.61M$ -15.1M$ -13.49M
9/30/2024$ 943K$ -19.11M$ -18.16M
6/30/2024$ 506K$ -17.41M$ -16.9M
3/31/2024$ 173K$ -18.05M$ -17.88M
12/31/2023$ 169K$ -16.55M$ -16.38M
9/30/2023$ 157K$ -23.37M$ -23.21M
6/30/2023$ 148K$ -22.64M$ -22.5M
3/31/2023$ 139K$ -24.34M$ -24.2M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • COSCIENS BIOPHARMA INC's latest trailing twelve months (TTM) EBITDA stands at $ -4.75M.
  • Over the past 5 years, COSCIENS BIOPHARMA INC's average EBITDA has been $ -13.86M.
  • The median EBITDA for COSCIENS BIOPHARMA INC during this period was $ -14.42M
  • COSCIENS BIOPHARMA INC reached its highest EBITDA over the past 5 years at $ -4.49M.
  • The lowest EBITDA recorded by COSCIENS BIOPHARMA INC in the same timeframe $ -24.2M

COSCIENS BIOPHARMA INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
CARM : CARISMA THERAPEUTICS INC $ -45.68MBOLT : BOLT BIOTHERAPEUTICS INC $ -47.13MTRAW : TRAWS PHARMA INC $ 87.92MVSEE : VSEE HEALTH INC $ -57.75MJAGX : JAGUAR HEALTH INC $ -38.7MMRKR : MARKER THERAPEUTICS INC $ -14.56MCYCN : CYCLERION THERAPEUTICS INC $ -1.95MLYRA : LYRA THERAPEUTICS INC $ -38.37MLGVN : LONGEVERON INC $ -17.38MHIND : VYOME HOLDINGS INC $ -4.43M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for COSCIENS BIOPHARMA INC is calculated as follows: EBIT [ $ -5M ] + DepAmor [ $ 248K ]
(=) EBITDA [ $ -4.75M ]

CSCIF - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -24.2M

Minimum

Mar 31, 2023

$ -4.49M

Maximum

Dec 31, 2020

$ -13.86M

Average

$ -14.42M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.87M with a standard deviation of $ 166.99M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.87M
median$ 8.87M
std$ 166.99M